A critical examination of summary measures of population health

Bulletin of the World Health Organization

Volumn 78, Issue 8, 2000, Pages 981-994

  Murray, Christopher J L ^a   Salomon, Joshua A ^a   Mathers, Colin ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cost of illness; Epidemiologic studies; Evaluation studies; Health status indicators

Indexed keywords

HEALTH STATUS; METHODOLOGY; MONITORING;

HEALTH CARE POLICY; HEALTH PROMOTION; HEALTH STATUS; LIFE EXPECTANCY; MEDICAL PRACTICE; MORTALITY; OUTCOMES RESEARCH; POPULATION RESEARCH; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK FACTOR;

AMERICAS; DEVELOPED COUNTRIES; EPIDEMIOLOGY; EVALUATION; EVALUATION METHODOLOGY; HEALTH; HEALTH STATUS INDEXES; NORTH AMERICA; NORTHERN AMERICA; PUBLIC HEALTH; RESEARCH REPORT; UNITED STATES;

DATA INTERPRETATION, STATISTICAL; EVALUATION STUDIES; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

EID: 0033837240     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Measuring community health levels
2. A single index of mortality and morbidity
3. A health-status index and its application to health services outcomes
4. Measuring the health status of populations
5. A quantitative method of assessing the health impact of different diseases in less developed countries
6. Health indices as a guide to health sector planning: A demographic critique
7. Active life expectancy
8. International efforts to measure health expectancy
9. Trends in health expectancy in Denmark, 1987-1994
10. Trends in disability-free life expectancy in the United States, 1970-90
11. Health expectancy calculations: A novel approach to studying population health in Bulgaria
12. Socioeconomic inequalities in health expectancy in Finland and Norway in the late 1980s
13. Health expectancy by level of education in Finland
14. Evidence-based health policy - Lessons from the Global Burden of Disease Study
15. Mortality by cause for eight regions of the world: Global Burden of Disease Study
16. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study
17. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
18. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
19. El peso de la enfermedad en adultos mayores, Mexico 1994
20. Burden of disease assessment and health system reform: Results of a study in Mexico
21. Estimating the burden of disease in an English region
22. Understanding DALYs
23. A framework for assessing the performance of health systems
24. Defining and measuring health inequality: An approach based on the distribution of health expectancy
25. Health inequalities and social group differences: What should we measure?
26. Ethical issues in the development of summary measures of population health status
27. Rethinking DALYs
28. Calculating the global burden of disease: Time for a strategic reappraisal?
29. DALYs: Efficiency versus equity
30. Distributive justice and the use of summary measures of population health status
31. Intergenerational equity. An exploration of the 'fair innings' argument
32. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection
33. Quality-adjusted life expectancy: Weighting of expected years in each state of health
34. Dementia-free life expectancy: Preliminary calculations for France and the United Kingdom
35. Measuring the health of the US population
36. The value of health
37. Decline in tuberculosis: The death rate fails to tell the entire story
38. Potential years of life lost between ages 1 and 70: An indicator of premature mortality for health planning
39. Measuring the burden of disease: Healthy life-years
40. The Framingham results on alcohol and breast cancer
41. Trends in fatal chronic diseases and disability in the Netherlands 1956-1993
42. Changes in incidence and survival of cardiovascular disease and their impact on disease prevalence and health expectancy
43. The length of working life
44. Active life expectancy for 10,000 Caucasian men and women in three communities
45. A multistate analysis of active life expectancy
46. How good is Sullivan's method for monitoring changes in population health expectancies?
47. Health expectancy: An indicator for change?
48. How good is Sullivan's method for monitoring changes in population health expectancies? Reply
49. Models of disablement, universalism and the international classification of impairments, disabilities and handicaps
50. In search of a contemporary theory for understanding mortality change
51. Evaluation of a population-based measure of quality of life: The health and activity limitation index (HALex)
52. EuroQol: A new facility for the measurement of health-related quality of life
53. Quality-adjusted life-years, utility theory and healthy-year equivalents
54. Are healthy-years equivalents an improvement over quality-adjusted life years?
55. QALYs versus HYEs
56. The person trade-off approach to valuing health care programs
57. Incorporating societal concerns for fairness in numerical valuations of health programmes
58. Cardinal utility in welfare economics and in the theory of risk-taking
59. Americans enjoy 70 healthy years, behind Europe, UN says
60. New look at longevity offers disease insight
61. Measuring and explaining the change in life expectancies
62. Gains in health expectancy from the elimination of diseases among older people
63. Potential gains in life expectancy free of disability: A tool for health planning
64. The elimination of selected chronic diseases in a population: The compression and expansion of morbidity
65. Health-adjusted life expectancy
66. On the comparable quantification of health risks: Lessons from the Global Burden of Disease Study
67. The health benefits of prevention: A simulation approach
68. Population interventions reassessed
69. Timeless epidemiology or history cannot be ignored
70. Preferences for life saving programs: How the public discounts time and age
71. Time preference in medical decision making and cost-effectiveness analysis
72. Rates of time preference and valuations of the duration of life
73. Isolation, assurance and the social rate of discount